NEW AMBRX BIOPHARMA INC (AMAM)
US6418711080 - Common Stock
ChartMill assigns a Buy % Consensus number of 76% to AMAM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 29.07. This target is 3.82% above the current price.
AMAM was analyzed by 14 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about AMAM.
In the previous month the buy percentage consensus was at a similar level.
AMAM was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-16 | Baird | Downgrade | Outperform -> Neutral |
| 2024-01-10 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-01-09 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2023-11-29 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-15 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-10-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-10-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-09-25 | JMP Securities | Initiate | Market Outperform |
| 2023-09-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-13 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-09-12 | BTIG | Initiate | Buy |
| 2023-08-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-31 | RBC Capital | Initiate | Outperform |
| 2023-06-14 | B. Riley Securities | Initiate | Buy |
| 2023-06-02 | Oppenheimer | Initiate | Outperform |
| 2023-05-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-04-05 | Baird | Maintains | Outperform |
| 2023-02-28 | Goldman Sachs | Maintains | Neutral |
| 2023-02-27 | Goldman Sachs | Maintains | Neutral |
| 2022-05-24 | Goldman Sachs | Maintains | Neutral |
| 2022-04-07 | Baird | Initiate | Outperform |
| 2022-02-28 | Goldman Sachs | Initiate | Neutral |
| 2021-07-13 | Cowen & Co. | Initiate | Outperform |
| 2021-07-13 | Goldman Sachs | Initiate | Buy |
| 2021-07-13 | B of A Securities | Initiate | Buy |